| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.53e-04 | 120 | 45 | 4 | GO:0004222 | |
| GeneOntologyBiologicalProcess | collagen catabolic process | 5.35e-06 | 53 | 45 | 4 | GO:0030574 | |
| GeneOntologyCellularComponent | lipid droplet | 1.13e-04 | 116 | 45 | 4 | GO:0005811 | |
| GeneOntologyCellularComponent | extracellular matrix | 4.67e-04 | 656 | 45 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 4.75e-04 | 658 | 45 | 7 | GO:0030312 | |
| Domain | M10A_MMP | 2.30e-07 | 23 | 44 | 4 | IPR033739 | |
| Domain | Pept_M10A | 2.30e-07 | 23 | 44 | 4 | IPR021190 | |
| Domain | Peptidase_M10 | 2.75e-07 | 24 | 44 | 4 | PF00413 | |
| Domain | ZnMc | 6.09e-07 | 29 | 44 | 4 | SM00235 | |
| Domain | Peptidase_Metallo | 6.09e-07 | 29 | 44 | 4 | IPR006026 | |
| Domain | Pept_M10_metallopeptidase | 3.09e-06 | 43 | 44 | 4 | IPR001818 | |
| Domain | Pept_M10A_stromelysin-type | 9.71e-06 | 18 | 44 | 3 | IPR016293 | |
| Domain | PG_binding_1 | 1.35e-05 | 20 | 44 | 3 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 1.35e-05 | 20 | 44 | 3 | IPR002477 | |
| Domain | Hemopexin-like_dom | 2.09e-05 | 23 | 44 | 3 | IPR000585 | |
| Domain | Hemopexin-like_repeat | 2.09e-05 | 23 | 44 | 3 | IPR018487 | |
| Domain | Hemopexin | 2.09e-05 | 23 | 44 | 3 | PF00045 | |
| Domain | HEMOPEXIN | 2.09e-05 | 23 | 44 | 3 | PS00024 | |
| Domain | - | 2.09e-05 | 23 | 44 | 3 | 2.110.10.10 | |
| Domain | HEMOPEXIN_2 | 2.09e-05 | 23 | 44 | 3 | PS51642 | |
| Domain | HX | 2.09e-05 | 23 | 44 | 3 | SM00120 | |
| Domain | DUF3377 | 3.24e-05 | 4 | 44 | 2 | PF11857 | |
| Domain | Pept_M10A_metallopeptidase_C | 3.24e-05 | 4 | 44 | 2 | IPR021805 | |
| Domain | MetalloPept_cat_dom | 3.91e-05 | 81 | 44 | 4 | IPR024079 | |
| Domain | - | 3.91e-05 | 81 | 44 | 4 | 3.40.390.10 | |
| Domain | ZINC_PROTEASE | 8.24e-05 | 98 | 44 | 4 | PS00142 | |
| Domain | CYSTEINE_SWITCH | 1.22e-04 | 41 | 44 | 3 | PS00546 | |
| Domain | Pept_M10A_Zn_BS | 5.59e-04 | 15 | 44 | 2 | IPR021158 | |
| Domain | Hemopexin_CS | 7.21e-04 | 17 | 44 | 2 | IPR018486 | |
| Domain | - | 1.22e-02 | 71 | 44 | 2 | 1.10.418.10 | |
| Pathway | WP_MATRIX_METALLOPROTEINASES | 4.99e-07 | 29 | 32 | 4 | MM15981 | |
| Pathway | WP_MATRIX_METALLOPROTEINASES | 5.75e-07 | 30 | 32 | 4 | M39652 | |
| Pathway | WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION | 3.34e-06 | 46 | 32 | 4 | M46450 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.65e-04 | 258 | 32 | 5 | MM14572 | |
| Pubmed | 4.82e-09 | 16 | 46 | 4 | 10949577 | ||
| Pubmed | 1.92e-08 | 22 | 46 | 4 | 10419448 | ||
| Pubmed | Functional interactions between matrix metalloproteinases and glycosaminoglycans. | 1.92e-08 | 22 | 46 | 4 | 23421805 | |
| Pubmed | 2.79e-08 | 24 | 46 | 4 | 15734845 | ||
| Pubmed | 3.55e-07 | 11 | 46 | 3 | 10949161 | ||
| Pubmed | TRPM7 controls mesenchymal features of breast cancer cells by tensional regulation of SOX4. | 1.71e-06 | 2 | 46 | 2 | 29684587 | |
| Pubmed | KIF1B promotes glioma migration and invasion via cell surface localization of MT1-MMP. | 1.71e-06 | 2 | 46 | 2 | 26576027 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 18617643 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 23354307 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 25411248 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 35062057 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 16980305 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 1.45e-05 | 853 | 46 | 8 | 28718761 | |
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 12661033 | ||
| Pubmed | Scrambler, a new neurological mutation of the mouse with abnormalities of neuronal migration. | 1.71e-05 | 5 | 46 | 2 | 8875886 | |
| Pubmed | MT3-MMP Promotes Excitatory Synapse Formation by Promoting Nogo-66 Receptor Ectodomain Shedding. | 1.71e-05 | 5 | 46 | 2 | 29196321 | |
| Pubmed | Cleavage of metastasis suppressor gene product KiSS-1 protein/metastin by matrix metalloproteinases. | 3.58e-05 | 7 | 46 | 2 | 12879005 | |
| Pubmed | Membrane-type matrix metalloproteinases: Their functions and regulations. | 3.58e-05 | 7 | 46 | 2 | 25794647 | |
| Pubmed | Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP). | 3.58e-05 | 7 | 46 | 2 | 10922468 | |
| Pubmed | 4.77e-05 | 8 | 46 | 2 | 1133851 | ||
| Pubmed | 6.12e-05 | 9 | 46 | 2 | 16113801 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 6.62e-05 | 774 | 46 | 7 | 15302935 | |
| Pubmed | Genotyping new BXD recombinant inbred mouse strains and comparison of BXD and consensus maps. | 9.34e-05 | 11 | 46 | 2 | 10087289 | |
| Pubmed | 9.94e-05 | 568 | 46 | 6 | 37774976 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.28e-04 | 861 | 46 | 7 | 36931259 | |
| Pubmed | FCHo proteins are nucleators of clathrin-mediated endocytosis. | 1.32e-04 | 13 | 46 | 2 | 20448150 | |
| Pubmed | 2.03e-04 | 16 | 46 | 2 | 20484597 | ||
| Pubmed | A series of recombinant inbred strains between the BALB/cHeA and STS/A mouse strains. | 3.54e-04 | 21 | 46 | 2 | 4042679 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 5.81e-04 | 1105 | 46 | 7 | 35748872 | |
| Pubmed | Genetic mapping of eight SH3 domain genes on seven mouse chromosomes. | 6.33e-04 | 28 | 46 | 2 | 10087302 | |
| Pubmed | 6.33e-04 | 28 | 46 | 2 | 24448406 | ||
| Pubmed | 7.06e-04 | 538 | 46 | 5 | 28524877 | ||
| Pubmed | 9.35e-04 | 34 | 46 | 2 | 1686571 | ||
| Pubmed | 1.05e-03 | 36 | 46 | 2 | 20587546 | ||
| Pubmed | 1.17e-03 | 156 | 46 | 3 | 29961565 | ||
| Pubmed | 1.18e-03 | 604 | 46 | 5 | 38803224 | ||
| Pubmed | 1.25e-03 | 916 | 46 | 6 | 32203420 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.32e-03 | 361 | 46 | 4 | 26167880 | |
| Interaction | MMP16 interactions | 7.74e-06 | 18 | 44 | 3 | int:MMP16 | |
| Interaction | MMP24 interactions | 9.18e-06 | 19 | 44 | 3 | int:MMP24 | |
| Interaction | CCL4L1 interactions | 2.16e-05 | 25 | 44 | 3 | int:CCL4L1 | |
| Interaction | MMP13 interactions | 4.18e-05 | 31 | 44 | 3 | int:MMP13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.38e-05 | 797 | 46 | 7 | chr19p13 | |
| Cytoband | 12q13.1 | 6.44e-05 | 12 | 46 | 2 | 12q13.1 | |
| Cytoband | 19p13.3 | 9.53e-05 | 237 | 46 | 4 | 19p13.3 | |
| Cytoband | 7p22.1 | 1.03e-03 | 47 | 46 | 2 | 7p22.1 | |
| Cytoband | 19p13.11 | 2.47e-03 | 73 | 46 | 2 | 19p13.11 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 5.55e-08 | 24 | 29 | 4 | 891 | |
| Coexpression | NABA_MATRISOME | 7.82e-06 | 1008 | 46 | 10 | MM17056 | |
| Coexpression | NABA_MATRISOME | 9.13e-06 | 1026 | 46 | 10 | M5889 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.10e-05 | 191 | 46 | 5 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.37e-05 | 196 | 46 | 5 | M3008 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP | 2.49e-05 | 198 | 46 | 5 | M8036 | |
| Coexpression | NABA_CORE_MATRISOME | 1.08e-04 | 270 | 46 | 5 | MM17057 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6 | 1.18e-04 | 54 | 46 | 3 | MM537 | |
| Coexpression | NABA_CORE_MATRISOME | 1.18e-04 | 275 | 46 | 5 | M5884 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6 | 1.24e-04 | 55 | 46 | 3 | M1284 | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 5.45e-08 | 198 | 46 | 6 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | AT1-AT2_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.01e-06 | 175 | 46 | 5 | 9a95ab5c361ebaa8747983c5a0d69025682a19ad | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-06 | 184 | 46 | 5 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-06 | 184 | 46 | 5 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.40e-06 | 187 | 46 | 5 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.60e-06 | 192 | 46 | 5 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-06 | 195 | 46 | 5 | 68f4cc84b5ae7f4159b780c78e4b66c94211779a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-06 | 195 | 46 | 5 | 2a1863f4b9fe73c30b0b1acf9b12fc98ef65040f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-06 | 196 | 46 | 5 | eb68f7954e7c2f86d05e740e95b6e74805a6053f | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.86e-06 | 198 | 46 | 5 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.95e-06 | 200 | 46 | 5 | e663995fc44c340d878d66b278b7b5c2ff784301 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.95e-06 | 200 | 46 | 5 | 2cb8a39a12522a9643c6244d5e94cb4559868bb9 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-3|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.95e-06 | 200 | 46 | 5 | 8cc5057b0e5ae9b72ea40d2ffbc52b79bf87ccef | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.35e-05 | 162 | 46 | 4 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | Mild-MAIT|World / Disease group and Cell class | 2.46e-05 | 164 | 46 | 4 | 21dc02997dfae73cf70ce291661928526605dba1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.58e-05 | 166 | 46 | 4 | c8a7d94ed762e5e045ab5f74eef691ddc5f74993 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 3.25e-05 | 176 | 46 | 4 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.39e-05 | 178 | 46 | 4 | e5e4742e35c3d90f82b830d77bdbdc45828c7deb | |
| ToppCell | moderate-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.55e-05 | 180 | 46 | 4 | 1d8df7df03a71f49d6683554d3c948ce90dda42e | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.78e-05 | 183 | 46 | 4 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.86e-05 | 184 | 46 | 4 | c7073d1b2c4fdb154d87678b92a0629c02116972 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.86e-05 | 184 | 46 | 4 | 1ed558a88215b248431c524ea16f13d9022ae98c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.95e-05 | 185 | 46 | 4 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_pDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.95e-05 | 185 | 46 | 4 | 308a98f111895071d8772bc010554471cc12fab2 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.11e-05 | 187 | 46 | 4 | 43ef900b76f3c38bd8ce9858201124130c743d56 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.11e-05 | 187 | 46 | 4 | 6e5c38425b6b1d4774f8dcea7e146f1eab785c3e | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 188 | 46 | 4 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 4.47e-05 | 191 | 46 | 4 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.56e-05 | 192 | 46 | 4 | f053b89bfd6048c227667ff01c38df7c51d8a496 | |
| ToppCell | Mild_COVID-19|World / Disease group,lineage and cell class (2021.01.30) | 4.65e-05 | 193 | 46 | 4 | 325b0768827bf8701bfb7f686bb11fd8b1a41a5c | |
| ToppCell | (1)_Osterolineage_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.65e-05 | 193 | 46 | 4 | 035eeea9f77c4bf9cd85f07fa791b6c857be76b5 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.84e-05 | 195 | 46 | 4 | b65511770ed67f7447847e2187555b362988af45 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.84e-05 | 195 | 46 | 4 | 07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904 | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.94e-05 | 196 | 46 | 4 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.94e-05 | 196 | 46 | 4 | cbfe01ba8071864e19b37028236ae35789f630fe | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.04e-05 | 197 | 46 | 4 | 69d5b8588046d119b5dff9a7fd6f49e97e00a5b7 | |
| ToppCell | AT1_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 5.04e-05 | 197 | 46 | 4 | 80d81be244c94c435accb643449b4ce6a3462c7f | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.04e-05 | 197 | 46 | 4 | e6cbfa267eb2e05b441fd034786faae07bb0e081 | |
| ToppCell | Biopsy_IPF-Epithelial-AT1|Biopsy_IPF / Sample group, Lineage and Cell type | 5.14e-05 | 198 | 46 | 4 | 75bdecbe111fededf6082b11de18b84ca308ef6d | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.14e-05 | 198 | 46 | 4 | c55608633f66e3d434c5d81324efb07c5120d2c2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.14e-05 | 198 | 46 | 4 | 3e5459038fc6ed95f529eb4d1dc5113e16c19012 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-05 | 198 | 46 | 4 | 54228dd9a50616d2022712d162a419ed0327cabd | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-I_(AT1)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.24e-05 | 199 | 46 | 4 | 5a002d49a8b84c158f7b4d7a3e78e6a937757bb7 | |
| ToppCell | normal_Lung-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 5.24e-05 | 199 | 46 | 4 | 2f6074a2fd3323f258be03042f77929640ad0a75 | |
| ToppCell | Biopsy_IPF-Epithelial-Transitional_AT2|Biopsy_IPF / Sample group, Lineage and Cell type | 5.24e-05 | 199 | 46 | 4 | 83ff8b7e472d1212324c05cc719b746d19e5e23b | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.34e-05 | 200 | 46 | 4 | 731e55070a7ff315091855bd88cda30e5a7e1a98 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.34e-05 | 200 | 46 | 4 | b6f21f5cc137eddf6ba90e81cae791b57d88d9d7 | |
| ToppCell | COVID-19-Fibroblasts-Pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 5.34e-05 | 200 | 46 | 4 | 73e01b7bc43320a991c67a4fd0c04708f893c7ea | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.34e-05 | 200 | 46 | 4 | 019340e8b4b4944a49e14fdec7ce2954cbb8ba2e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.34e-05 | 200 | 46 | 4 | 082e718c1da3f4fdd33a001d15ad3ddb2be985c7 | |
| ToppCell | (5)_Fibroblast-H|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.34e-05 | 200 | 46 | 4 | 94e77a1082ade6fad93a37168e037af8aefe7ff4 | |
| ToppCell | severe-NK|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.34e-05 | 200 | 46 | 4 | d6767f06fe13be8110a86c2a6029be2dd9ce666c | |
| ToppCell | Mild/Remission-B_naive-13|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.23e-04 | 142 | 46 | 3 | 49873a2d9b1ae4bdbf253d1c09bf8845cc0cc917 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.59e-04 | 146 | 46 | 3 | 447c05414eda71681a0c07baba900f88ed6165ed | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_26.46.91|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-04 | 148 | 46 | 3 | df6bc387cad2f81520bd8bbd009c8e63225dbadb | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.26e-04 | 153 | 46 | 3 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.26e-04 | 153 | 46 | 3 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | AT1-AT2_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 5.46e-04 | 155 | 46 | 3 | 010e45ef4b505bf419ea41e4d1619521d1c78319 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-04 | 158 | 46 | 3 | c870fd17213129943562487338e2669e2930d719 | |
| ToppCell | IIF-Lymphocyte-T_NK-CD4_CTL|IIF / Disease, Lineage and Cell Type | 5.88e-04 | 159 | 46 | 3 | 64e2b57e09bf25b2582f154375bb88cfd02a2521 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-2_VIP_PPAPDC1A|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.99e-04 | 160 | 46 | 3 | 7619c31815e41a42864b34ca825c96a2487a5da9 | |
| ToppCell | ILEUM-non-inflamed-(3)_pDC|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.32e-04 | 163 | 46 | 3 | bc5411702badab39143905aa51676b4bbfad2041 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.43e-04 | 164 | 46 | 3 | aff5138b35a06b0819e52855744797bfa343633a | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 6.55e-04 | 165 | 46 | 3 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD8-Tem/emra_CD8|GI_large-bowel / Manually curated celltypes from each tissue | 6.66e-04 | 166 | 46 | 3 | 13bef304ea3df8e8d2bc376a3287c78220a1b0c6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-04 | 166 | 46 | 3 | dc443a3327dc8f9a0d808c3c6e06b0834d45f5c2 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.66e-04 | 166 | 46 | 3 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | Control-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 6.90e-04 | 168 | 46 | 3 | d7118d39253ed9790908b850088ebfc5a86f4065 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.90e-04 | 168 | 46 | 3 | c34dd4a9c54d8e9c8f118e6a3816548890cb0746 | |
| ToppCell | myeloid-Monocyte-CD14+_Monocyte|Monocyte / Lineage, cell class and subclass | 7.02e-04 | 169 | 46 | 3 | 7c3144a6599787f28662f5b22b8e45f4a115aeda | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.02e-04 | 169 | 46 | 3 | 0d96c0b4fd26fbc0bf44ff7bed2936eebcc55b74 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.02e-04 | 169 | 46 | 3 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.02e-04 | 169 | 46 | 3 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.02e-04 | 169 | 46 | 3 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.14e-04 | 170 | 46 | 3 | 6c65ddb496030bb479ef346cc37a9d4dfa6b824f | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.26e-04 | 171 | 46 | 3 | bdd30100b74e012eec3090799c22635aa57fa91d | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 7.39e-04 | 172 | 46 | 3 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-04 | 174 | 46 | 3 | 4cdf2eedc28d88d18241ee390092426fdf849e79 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.64e-04 | 174 | 46 | 3 | edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-04 | 174 | 46 | 3 | 268be5e7d2a18b866770b7cdb966c3958c7e6534 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.64e-04 | 174 | 46 | 3 | 65539f69100db0b7d90b1b39ee15ab8281f86461 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB|TCGA-Thymus / Sample_Type by Project: Shred V9 | 7.76e-04 | 175 | 46 | 3 | 50f9b994bdd389158f92f891944ea81b2fb15eef | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.76e-04 | 175 | 46 | 3 | 8fb8c4b9e2d9b7d737f59cd9bd3dc2bca5a8dfc4 | |
| ToppCell | 343B-Myeloid-Monocyte-CD14+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 7.78e-04 | 40 | 46 | 2 | 55acdee7651d5b2bf8f37a79d13e9f4ea7c79eb7 | |
| ToppCell | Control-Lymphoid-pDC|Control / Condition, Lineage and Cell class | 7.89e-04 | 176 | 46 | 3 | 5de16ff65476bde8b23322a44e11412e14f1bafe | |
| ToppCell | Control-Myeloid-pDC|Control / Disease group,lineage and cell class (2021.01.30) | 7.89e-04 | 176 | 46 | 3 | baa3563973ea1a351fe028f55828463d2a51bf1a | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.89e-04 | 176 | 46 | 3 | a8875b4ba4abf6625cdeb67bf544ce1573c59060 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.89e-04 | 176 | 46 | 3 | 238244294d08975df6bfa26b2b437db3654408ae | |
| ToppCell | ILEUM-inflamed-(3)_pDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.89e-04 | 176 | 46 | 3 | b9f847dd55703e413f3cd815eef5724fffaf13b3 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.02e-04 | 177 | 46 | 3 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-04 | 178 | 46 | 3 | ef490b45901b2e6dedb519540fa3ae4e4db3a9ba | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-04 | 178 | 46 | 3 | 445fb243d738a34794d66f34b92dde1f3ea6738e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.16e-04 | 178 | 46 | 3 | f3b5eeca6081d65d48824b5d13e3b8eb5fdeb2dd | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.29e-04 | 179 | 46 | 3 | b7281160c84dd053a2981c9c76ea6cc6d2592cd5 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.29e-04 | 179 | 46 | 3 | ff678e2f33c914e3dd0f338ada25f506c3e3c980 | |
| ToppCell | AT1_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 8.42e-04 | 180 | 46 | 3 | ff4728782c3ec814ba071cc22b7894abdd9da837 | |
| ToppCell | Severe-Lymphoid-pDC|Severe / Condition, Lineage, Cell class and cell subclass | 8.56e-04 | 181 | 46 | 3 | 2caecb7c5dcdad46fd02b4ffb73cb613ce835187 | |
| ToppCell | Severe-Lymphoid-pDC-|Severe / Condition, Lineage, Cell class and cell subclass | 8.56e-04 | 181 | 46 | 3 | 277ce4c49121da0990a5933b19d2c6af9bbe253e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-04 | 182 | 46 | 3 | d568a8aec7e27ce632e248baea2ccd0e8dd255ac | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-04 | 182 | 46 | 3 | e89cc30db8e5c77a8bbddd1d5a4b5af09f1ccd67 | |
| Drug | malolactomycin D | 4.60e-07 | 32 | 45 | 4 | CID006449115 | |
| Drug | diacerein | 7.28e-06 | 63 | 45 | 4 | CID000026248 | |
| Drug | pirfenidone | 7.65e-06 | 138 | 45 | 5 | CID000040632 | |
| Drug | enantio-PAF-C16 | 8.18e-06 | 244 | 45 | 6 | CID000002499 | |
| Drug | AC1L1GXT | 1.38e-05 | 74 | 45 | 4 | CID000003890 | |
| Drug | AC1NSU5S | 1.46e-05 | 75 | 45 | 4 | CID005316299 | |
| Drug | DA-125 | 1.82e-05 | 26 | 45 | 3 | CID000114758 | |
| Drug | titanium | 2.10e-05 | 170 | 45 | 5 | CID000023963 | |
| Drug | AC1L1DD6 | 2.69e-05 | 179 | 45 | 5 | CID000002299 | |
| Drug | mercuric acetate | 2.82e-05 | 30 | 45 | 3 | CID000015337 | |
| Drug | Antazoline hydrochloride [2508-72-7]; Up 200; 13.2uM; HL60; HG-U133A | 3.95e-05 | 194 | 45 | 5 | 1556_UP | |
| Drug | Calciferol [50-14-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 4.25e-05 | 197 | 45 | 5 | 3304_UP | |
| Drug | Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; PC3; HT_HG-U133A | 4.25e-05 | 197 | 45 | 5 | 6359_DN | |
| Drug | tamoxifen citrate; Down 200; 1uM; MCF7; HG-U133A | 4.46e-05 | 199 | 45 | 5 | 380_DN | |
| Drug | oxidized glutathione | 8.32e-05 | 227 | 45 | 5 | CID000000975 | |
| Disease | neuroblastoma (is_implicated_in) | 9.27e-05 | 10 | 43 | 2 | DOID:769 (is_implicated_in) | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.45e-03 | 153 | 43 | 3 | EFO_0004611, EFO_0020946 | |
| Disease | high grade glioma (is_implicated_in) | 1.72e-03 | 42 | 43 | 2 | DOID:3070 (is_implicated_in) | |
| Disease | high grade glioma (implicated_via_orthology) | 1.89e-03 | 44 | 43 | 2 | DOID:3070 (implicated_via_orthology) | |
| Disease | body fat distribution | 3.19e-03 | 202 | 43 | 3 | EFO_0004341 | |
| Disease | transitional cell carcinoma (is_marker_for) | 3.83e-03 | 63 | 43 | 2 | DOID:2671 (is_marker_for) | |
| Disease | breast carcinoma (is_marker_for) | 4.19e-03 | 66 | 43 | 2 | DOID:3459 (is_marker_for) | |
| Disease | wellbeing measurement, alcohol consumption measurement | 5.24e-03 | 74 | 43 | 2 | EFO_0007869, EFO_0007878 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GDHGDELFSVFGAPF | 466 | P23141 | |
| KREPFSGDHSADGFE | 36 | P15514 | |
| GPKEDGGFRHSEAFE | 386 | Q07065 | |
| EHFPHFSEPGDDFGE | 466 | Q6ULP2 | |
| FDHLAAFDGASEEAP | 316 | Q5VXM1 | |
| DGSGPFLADFNGFSH | 1631 | O00468 | |
| HFDKDHGGALGPEEF | 776 | O43707 | |
| DDGFFVPHGYLSEDE | 631 | Q13111 | |
| EAEAEAAAGGPHFLD | 316 | Q8N5I2 | |
| DEDAHFFSVGASGGP | 896 | Q2TAZ0 | |
| EGGLDDSGEHFFDAR | 1371 | Q9NZN5 | |
| FAEGFHGDSTPFDGE | 181 | P50281 | |
| EGAFSNDHIAGFPDL | 331 | P0C881 | |
| EGAFSNDHIAGFPDL | 331 | B2RC85 | |
| FGPPLESAFDHEDFT | 436 | O14526 | |
| DSSPFDGEGGFLAHA | 231 | Q9Y5R2 | |
| ESGFDTAFVDHNPDG | 56 | Q96QH8 | |
| EGSDLFSDGHDPFYD | 951 | O60333 | |
| FSLDQPDHGDSDFGL | 26 | Q9HBH9 | |
| EEGDSSGFEHVFSGE | 276 | P21128 | |
| TDAGPDSDFHANGTD | 346 | Q86XN8 | |
| DFAHFGFPSDNSGKE | 251 | Q8TB73 | |
| EGNPFDHFSAGESGL | 156 | Q86V85 | |
| DAGDAFDGFDFGDDP | 311 | P02679 | |
| FGDDPSDKFFTSHNG | 321 | P02679 | |
| LGEAFASDEPFDFGT | 566 | Q8NI60 | |
| GEHTEFSGDLDDGLF | 296 | Q96GE4 | |
| DGTFEPAEGLAGFHS | 201 | Q5T7N3 | |
| DDPFGAHGDFTADDL | 46 | Q8WXE1 | |
| DEDSPGGDFDFFSNL | 121 | Q9NRG7 | |
| RHDDGNFFPGSGAVD | 731 | Q8WUI4 | |
| FENGDHGDSYPFDGP | 171 | O60882 | |
| TGDFEDDFDAPFNPH | 696 | Q6ZW31 | |
| PGHDFRGGDFSSSDF | 91 | P78332 | |
| DLDFNFEPGSGSHFE | 431 | Q06945 | |
| EQFAGDGFHADGDDV | 451 | Q6ZMQ8 | |
| AFFPPHGGIHFDDSE | 171 | O75900 | |
| DGSGDSHPDFPEDAD | 196 | Q08752 | |
| SWFNVDHPGGDGDFE | 61 | Q8IUL8 | |
| FDAHEGFSDSEEVFP | 351 | O00562 | |
| DFEPENDGELGFHEG | 316 | Q99961 | |
| ESFGEVDFSHEGPAF | 206 | P17643 | |
| FSLDGAGAHFPDREE | 131 | Q96J42 | |
| LEFFGFEDHETGGDE | 426 | Q7Z5K2 | |
| GHFGDGDAAIWPDAF | 381 | Q4G0T1 | |
| PFESSSEEEFGGEDH | 291 | Q9NV66 | |
| EGDNTEFGAFVGHRD | 1431 | Q96QT4 |